Company / Revenue
HARVARD BIOSCIENCE INC Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$94.1M
FY2025
5-year range
$94.1M / $118.9M
FY2021-FY2025
Trend
-16.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has declined for 3 consecutive years, from $119M in FY2022 to $94M in FY2025.
Based on SEC 10-K filings.
$94M in FY2025 with a 5-year CAGR of -4.1%.
Declined from $113M to $94M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -7.5%
- 5-Year CAGR
- -4.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- HARVARD BIOSCIENCE INC's revenue has declined for 3 consecutive years.
- 5-year CAGR of -4.1%, indicating a declining trend.
- In FY2025, revenue decreased 16.1% year-over-year.
- Peak revenue was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $94.1M | -16.1% |
| FY2024 | $112.3M | -1.0% |
| FY2023 | $113.3M | -4.7% |
| FY2022 | $118.9M | +16.5% |
| FY2021 | $102.1M | -12.1% |
| FY2020 | $116.2M | -3.8% |
| FY2019 | $120.8M | +56.0% |
| FY2018 | $77.4M | -28.8% |
| FY2017 | $108.7M | +0.0% |
| FY2016 | $108.7M | +3.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026